Abbott Biotech Ventures, Inc. (ABVI) is a subsidiary of Abbott dedicated to making venture capital investments in emerging biotech and pharmaceutical companies. Unlike traditional venture capital firms, ABVI characterizes an investment’s success by its potential to significantly increase Abbott’s strategic growth, and not solely by its financial return.